BTTX — Better Therapeutics Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
Brief: Better Therapeutics Files For Offering Up To 479,516 Shares Of Common Stock - SEC Filing
Brief: Better Therapeutics, Inc. Q2 basic EPS USD -0.24
Better Therapeutics Inc reports results for the quarter ended in June - Earnings Summary
Better Therapeutics Inc expected to post a loss of 31 cents a share - Earnings Preview
Brief: Mmcap International Discloses Passive Stake Of 9.53% In Better Therapeutics As Of July 27 - SEC Filing
Brief: Better Therapeutics Announces $6.7 Million In New Financing
U.S. STOCKS ON THE MOVE-Zillow Group, TransAlta, Everbridge
U.S. STOCKS ON THE MOVE-EBay, Newell Brands, Semler Scientific
U.S. STOCKS ON THE MOVE-VeriSign, Equitrans Midstream, Nutrien
U.S. STOCKS ON THE MOVE-JPMorgan, Better Therapeutics, Equitrans Midstream
Better Therapeutics rises on FDA authorization for its diabetes treatment application
Brief: Better Therapeutics Receives FDA Authorization For Aspyrerx™ To Treat Adults With Type 2 Diabetes
Brief: Better Therapeutics Gets Letters From Nasdaq That It Is Not In Compliance With Minimum Bid Price Requirement
Better Therapeutics Inc reports results for the quarter ended in March - Earnings Summary
Brief: Better Therapeutics Reports Q1 2023 Financial Results And Provides Business Updates
Better Therapeutics Inc expected to post a loss of 74 cents a share - Earnings Preview
RCS - Envision Pharma Grp - Envision Names Dr. Jaggi to Board of Directors
Brief: Better Therapeutics To Release First Quarter 2023 Financial Results
Brief: Better Therapeutics Inc Regains Compliance With Nasdaq Continued Listing Standards